Amedica Receives Positive Nasdaq Listing Decision
December 01 2017 - 9:00AM
Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative
biomaterial company that develops and manufactures silicon nitride
as a platform for biomedical applications, announced today that on
November 27, 2017, the Company received formal notice from The
NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Company has
evidenced full compliance with all requirements for continued
listing on The Nasdaq Capital Market. Accordingly, the
previously-disclosed listing matter has been resolved and the
Company’s securities will continue to be listed on Nasdaq.
About Amedica
CorporationAmedica is focused on the development and
application of medical-grade silicon nitride ceramics. Amedica
markets spinal fusion products and is developing a new generation
of wear- and corrosion-resistant implant components for hip and
knee arthroplasty. The Company manufactures its products in its ISO
13485 certified manufacturing facility and, through its partnership
with Kyocera, the world's largest ceramic manufacturer. Amedica's
spine products are FDA-cleared, CE-marked, and are currently
marketed in the U.S. and select markets in Europe and South America
through its distributor network and its OEM partnerships.
For more information on Amedica
or its silicon nitride material platform, please
visit www.amedica.com.
Forward-Looking Statements
This press release contains statements that
constitute forward-looking statements within the meaning of the
Securities Act of 1933 and the Securities Exchange Act of 1934, as
amended by the Private Securities Litigation Reform Act of 1995.
These statements are based upon our current expectations and speak
only as of the date hereof. Our actual results may differ
materially and adversely from those expressed in any
forward-looking statements as a result of various factors and
uncertainties. For example, there can be no assurance that we will
regain compliance with the applicable criteria within the period of
time granted by the Panel and that we will be able to maintain our
listing on any NASDAQ market. Other factors that could cause
actual results to differ materially from those contemplated within
this press release can also be found in Amedica's Risk Factors
disclosure in its Annual Report on Form 10-K, filed with the
Securities and Exchange Commission (SEC) on September 20, 2017, and
in Amedica's other filings with the SEC. Forward-looking
statements contained in this press release speak only as of the
date of this press release. We undertake no obligation to update
any forward-looking statements as a result of new information,
events or circumstances or other factors arising or coming to our
attention after the date hereof.
Contact:
Amedica IR
801-839-3502
IR@amedica.com
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Apr 2024 to May 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From May 2023 to May 2024